Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 4 10Phase 3 4Phase 2 4Phase 2/3 2Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 1Leiomyoma 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Completed × Clomiphene × Clear all
NCT06813118 2026-05-07

Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

HITEC-Institute of Medical Sciences

Phase 1 Completed
42 enrolled

Polycystic Ovary Syndrome

NCT04177693 2023-06-05

Pharmacokinetics and Hepatic Safety of EGCG

Yale University

Phase 1 Completed
39 enrolled 18 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡